SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-001446
Filing Date
2018-10-01
Accepted
2018-10-01 20:03:20
Documents
1
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 form4-10012018_051005.html 4  
1 form4-10012018_051005.xml 4 3280
  Complete submission text file 0001415889-18-001446.txt   4712
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address
BORKOWSKI EDWARD (Reporting) CIK: 0001197542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 181098968

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1